Dr. Tammy S. Ho, MD

Dr. Ho practices at Hoag Outpatient Centers in Newport Beach, California.

Dr. Ho's NPI, 1003179128, was assigned on June 22, 2012. Dr. Ho graduated from Duke University School Of Medicine in 2012. Dr. Ho holds California license 149421.

Dr. Ho's primary practice is Hoag Outpatient Centers, at 500 Superior Ave, Newport Beach, CA 92663 in Orange County. The practice phone is (949) 520-7804.

Dr. Ho's primary practice is Hoag Outpatient Centers in Newport Beach, California. Dr. Ho is also affiliated with Hoag Hospital Newport Beach. The medical group on file is UCI Health Center for Urological Care. Dmand AI also links Dr. Ho to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ho practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Ho's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Ho is board certified in urology by the American Board of Urology. Dmand AI has Dr. Ho's licenses on file in 2 states: California and Missouri.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Ho treats.

CMS data shows 2,756 Medicare services from Dr. Ho across 16 procedure codes in 2024, for 501 Medicare patients. Medicare paid $164,907 for them.

CMS counts 501 Medicare patients who saw Dr. Ho in 2024. The largest group is 65 to 74, with 209 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ho's median patient age at 70, with 44% women.

In 2024, Dr. Ho wrote 2,807 Medicare Part D claims for 852 patients. 78% of them were for generic drugs. CMS names the drug for 2,681 of them, across 28 drugs with 11 or more claims each, at $493,919 in total drug cost. In 2023, CMS named 2,492 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Ho for performance year 2024, reported as part of a group. Dr. Ho accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ho as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Ho, published from 2014 to 2017. Dr. Ho's most frequent co-authors are Gerald L. Andriole, MD, Steven Benjamin Brandes, MD and Douglas E. Coplen, MD.

Dmand AI links Dr. Ho to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 239 general payments to Dr. Ho from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 79% of the total. Boston Scientific Corporation paid the most, $3,095.

Dr. Ho graduated from Duke University School Of Medicine in 2012.

Dr. Ho is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.